Carótidas + Ecoestresse = Futuro cardiovascular

Long-Term Prognostic Value of Simultaneous Assessment of Atherosclerosis and Ischemia in Patients with Suspected Angina: Implications for Routine Use of Carotid Ultrasound during Stress Echocardiography

https://doi.org/10.1016/j.echo.2019.11.019

.

  • •Carotid plaque burden is associated with cardiovascular events.
  • •Carotid ultrasound provides incremental prognostic information in suspected angina.

In patients with suspected stable angina with no history of cardiovascular disease, carotid atherosclerosis and myocardial ischemia detected by ultrasound provided synergistic information for the long-term prediction of events, but atherosclerosis predicted hard events beyond myocardial ischemia, particularly in patients with a normal SE.

.

KM impact of CPB divided into three groups. (color), (A) MAE, (B) MACE, (C) hard event, (D) cardiac hard event.

Válvulas em pessoas acima de 60 anos

https://doi.org/10.1093/ehjci/jeae127

.

Conclusion

Asymptomatic VHD is present in a significant proportion of otherwise healthy individuals without known VHD over 60 years old. Age is strongly associated with an increased incidence of significant VHD.

.

Quando criamos o laudo de um certo laboratório da capital, em 2000, deixamos um modelo pronto chamado “idoso”

.

Já vinha descrito o espessamento leve valvar Mitral e Aórtico.

Com refluxo leve em ambos!

.

Veja que 1/4 dos indivíduos assintomáticos tinham algum achado!

.

Só discordamos do relato de insuficiência Tricuspide como achado patológico. Quase todos os pacientes tem!

.

Reduz peso e ingesta? Reduz IMT

Figure 1. Effectiveness parameters. (A) Carotid intima-media thickness (mm) variation by visit, all patients (T0, n = 40; T4, n = 40). (B) HbA1c (%) variation by visit, all patients (T0, n = 40; T4, n = 40). cIMT: carotid intima-media thickness. Paired samples t-test; *** p < 0.001.

.

https://doi.org/10.3390/biomedicines11051362

.

Conclusions: Our findings suggest the effect of injectable semaglutide on atherosclerosis as a key CV protective mechanism.

.

Glycemic parameters:
Glycemia (mg/dL)176 ± 75122 ± 22<0.001
HbA1c (%)9 ± 27 ± 1<0.001
Carotid IMT1 ± 0.10.9 ± 0.1<0.001

IMT voltando como marcador de risco cardiovascular e marcador substituto.